Chemoenzymatic Synthesis of Selegiline: An Imine Reductase-Catalyzed Approach
Molecules · 2024
DOI: 10.3390/molecules29061328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Yuliang Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang 330045, China. Hauptthemen laut MEDLINE: Oxidoreductases, Selegiline. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Strategic Priority Research Program, CAS, National Natural Science Foundation of China.
Abstract (Originalsprache)
(R)-Homobenzylic amines are key structural motifs present in (R)-selegiline, a drug indicated for the treatment of early-stage Parkinson’s disease. Herein, we report a new short chemoenzymatic approach (in 2 steps) towards the synthesis of (R)-selegiline via stereoselective biocatalytic reductive amination as the key step. The imine reductase IR36-M5 mutant showed high conversion (97%) and stereoselectivity (97%) toward the phenylacetone and propargyl amine substrates, offering valuable biocatalysts for synthesizing alkylated homobenzylic amines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang 330045, China.
- Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China.
- National Technology Innovation Center of Synthetic Biology, Tianjin 300308, China.
ORCID-Profile: Chengsen Cui
Förderung
- National Key Research and Development Program of China
- Strategic Priority Research Program, CAS
- National Natural Science Foundation of China
- "Innovative Cross Team" project, CAS
- Young Scientists Innovation Promotion Association of CAS
- Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project
- “Innovative Cross Team” project, CAS
Zitieren
APA
Hu, Y., Bao, J., Tang, D., Gao, S., Wang, F., Ding, Z., & Cui, C. (2024). Chemoenzymatic Synthesis of Selegiline: An Imine Reductase-Catalyzed Approach. Molecules. https://doi.org/10.3390/molecules29061328
Vancouver
Hu Y, Bao J, Tang D, Gao S, Wang F, Ding Z, et al. Chemoenzymatic Synthesis of Selegiline: An Imine Reductase-Catalyzed Approach. Molecules. 2024. doi:10.3390/molecules29061328
BibTeX
@article{Hu2024,
author = {Hu, Yuliang and Bao, Jinping and Tang, Dongyu and Gao, Shushan and Wang, Fei and Ding, Zhongtao and Cui, Chengsen},
title = {Chemoenzymatic Synthesis of Selegiline: An Imine Reductase-Catalyzed Approach},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29061328}
}
EUVIMED